Associated Evaluation and Approval of Drugs and Medical Devices in China and the Inspiration for Cosmetic Ingredient Management and Cosmetics Safety Evaluation

Su Zhe, He Miao, Hu Kang, Zhang Fenglan, Yu Zhenxi, Wang Gangli, Lu Yong

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (2) : 150-156.

Chinese Pharmaceutical Affairs ›› 2023, Vol. 37 ›› Issue (2) : 150-156. DOI: 10.16153/j.1002-7777.2023.02.004
Supervision Administration

Associated Evaluation and Approval of Drugs and Medical Devices in China and the Inspiration for Cosmetic Ingredient Management and Cosmetics Safety Evaluation

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2023, 37(2): 150-156 https://doi.org/10.16153/j.1002-7777.2023.02.004

References

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}

Accesses

Citation

Detail

Sections
Recommended

/